Receptor-targeted image-guided Radionuclide Therapy (TRT) is increasingly recognized as
a promising approach to cancer treatment. In particular, the potential for clinical translation of …

This article highlights recent developments of SPECT and PET diagnostic imaging
surrogates for targeted alpha particle therapy (TAT) radiopharmaceuticals. It outlines the …

Abstract Introduction 203 Pb (t 1/2= 51.9 h, 279 keV (81%)) is a diagnostic SPECT imaging
radionuclide ideally suited for theranostic applications in combination with 212 Pb for …

This continuing education analyzes recent advances in Nuclear Medicine focused on the
development of new radiopharmaceuticals that improve both the diagnosis and treatment of …

En esta formación continuada se analizan los recientes avances en Medicina Nuclear
centrados en el desarrollo de nuevos radiofármacos que mejoran tanto el diagnóstico como …